ICSBP-mediated immune protection against BCR-ABL-induced leukemia requires the CCL6 and CCL9 chemokines.

Venue / Journal

Blood

Date

Thu, 04/16/2009 - 12:00

Additional Journal Information

113(16):3813-20

Authors

Nardi V, Naveiras O, Azam M, Daley GQ.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/19171873